Hollman G, Shen G, Zeng L, Yngsdal-Krenz R, Perloff W, Zimmerman J, Strauss R
University of Wisconsin Children's Hospital, Madison 53792-4108, USA.
Crit Care Med. 1998 Oct;26(10):1731-6. doi: 10.1097/00003246-199810000-00031.
To determine the efficacy of a helium-oxygen mixture in children admitted to the pediatric intensive care unit with acute respiratory syncytial virus (RSV) bronchiolitis.
Randomized, double-blind, controlled, crossover study and nonrandomized, prospective study.
A pediatric intensive care unit in a university hospital.
Nonintubated children with signs of acute lower respiratory tract infection and a positive rapid immunoassay for RSV admitted to the pediatric intensive care unit.
Treatment with either helium-oxygen or air-oxygen was administered in random order for 20 mins. Nonrandomized patients received helium-oxygen as initial therapy.
Clinical Asthma Score, respiratory rate, heart rate, and pulse oximetry oxygen saturation values were recorded at baseline (before randomization) and at the end of each 20-min treatment period (helium-oxygen or air-oxygen). Nonrandomized patients were studied 20 mins into helium-oxygen delivery. Eighteen patients were studied, 13 of whom were randomized. Five children with severe bronchiolitis (Clinical Asthma Score of > or =6) were initially given helium-oxygen and scored at 20 mins. Mean Clinical Asthma Score was 3.04 (range 1 to 7.5) in the 13 randomized patients and 4.25 (range 1 to 9) in the 18 patients overall. Clinical Asthma Score decreased in the 13 randomized patients (mean 0.46, p < .05) and in the 18 patients overall (mean 1.23, p < .01) during helium-oxygen delivery. In randomized patients with Clinical Asthma Scores of <6 (n = 12), a positive correlation (rs = .72) was observed between the Clinical Asthma Score at baseline and the change in Clinical Asthma Score during helium-oxygen administration (p = .009). Respiratory rate and heart rate decreased during helium-oxygen treatment but were not statistically significant. No complications occurred during helium-oxygen delivery.
Inhaled helium-oxygen improves the overall respiratory status of children with acute RSV lower respiratory tract infection. In patients with mild-to-moderate bronchiolitis (Clinical Asthma Scores of <6), the beneficial effects of helium-oxygen were most pronounced in children with the greatest degree of respiratory compromise.
确定氦氧混合气对入住儿科重症监护病房的急性呼吸道合胞病毒(RSV)细支气管炎患儿的疗效。
随机、双盲、对照、交叉研究以及非随机前瞻性研究。
一所大学医院的儿科重症监护病房。
入住儿科重症监护病房、有急性下呼吸道感染体征且RSV快速免疫测定呈阳性的非插管患儿。
氦氧混合气或空气氧气以随机顺序给药20分钟。非随机分组的患者接受氦氧混合气作为初始治疗。
在基线(随机分组前)以及每个20分钟治疗期(氦氧混合气或空气氧气)结束时记录临床哮喘评分、呼吸频率、心率和脉搏血氧饱和度值。对非随机分组的患者在给予氦氧混合气20分钟后进行研究。共研究了18例患者,其中13例进行了随机分组。5例重度细支气管炎患儿(临床哮喘评分为≥6)最初给予氦氧混合气并在20分钟时进行评分。13例随机分组患者的平均临床哮喘评分为3.04(范围1至7.5),18例患者总体平均临床哮喘评分为4.25(范围1至9)。在给予氦氧混合气期间,13例随机分组患者的临床哮喘评分下降(平均0.46,p<0.05),18例患者总体临床哮喘评分下降(平均1.23,p<0.01)。在临床哮喘评分<6的随机分组患者(n = 12)中,观察到基线时的临床哮喘评分与氦氧混合气给药期间临床哮喘评分变化之间呈正相关(rs = 0.72)(p = 0.009)。氦氧混合气治疗期间呼吸频率和心率下降,但无统计学意义。给予氦氧混合气期间未发生并发症。
吸入氦氧混合气可改善急性RSV下呼吸道感染患儿的整体呼吸状况。在轻度至中度细支气管炎患者(临床哮喘评分<6)中,氦氧混合气的有益效果在呼吸功能受损最严重的患儿中最为明显。